Contemporary and emergent pharmacological therapies for chronic pain: nonopioid analgesia

References

• Merskey H, Bogduk N. International Association for the Study of Pain (IASP). Classification of Chronic Pain (2nd Edition) Seattle, USA. IASP Press. (1994).
   Google Scholar
• Pappagallo M. Aggressive pharmacologic treatment of pain. In: Pain Management in the Rheumatic Diseases (Pisetsky DS, Bradley L, Eds.). Rheumatic Disease Clinics of North America, Feb 25; 1,193-213 (1999).
   Google Scholar
• Baron R. Peripheral neuropathic pain: from mechanisms to symptoms. Clin. J. Pain 16(2), S12-20 (2000).
   Google Scholar
• Bennett GJ. Scientific basis for the evaluation and treatment of RSD/CRPS syndromes: laboratory studies in animals and man. In: Pain 1999 -An updated rerdew (Max M Ed.) IASP Press, Seattle, USA, 331–337 (1999).
   Google Scholar
• Asbury AK. Diseases of the peripheral nervous system. In: Hatrisoni Principles of Internal Medicine (Isselbacher KJ et alEds) (14th Edition). Mc Graw-Hill, New York, USA 2457–2469 (2000).
   Google Scholar
• Backonja MM, Galer BS. Pain assessment and evaluation of patients who have neuropathic pain. Neural Clin. 16(4), 775–790 (1998).
   Google Scholar
• Campbell JN.Complex regional pain syndrome and the sympathetic nervous system. In: Pain 1996- An updated review (Campbell, JN Ed.), IASP Press, Seattle, USA, 89–96 (1996).
   Google Scholar
• Jensen MP, Strom SE, Turner JA, et al Validity of the Sickness Impact Profile Roland Scale as a measure of dysfunction in chronic pain patients. Pa/n50(2), 157–162 (1992).
   Google Scholar
• Riley JL, Zawacki TM, Robinson ME, Geisser ME. Empirical test of the factor structure of the West Haven-Yale Multidimensional Pain Inventory. Clin. Pain. 15(1), 24–30 (1999).
   Web of Science ®Google Scholar
• Bergstrom G, Jensen TB, Bodin L et al Reliability and factor structure of the Multidimensional Pain Inventory-Swedish Language Version (MPI-S). Pain 75(1), 101–110 (1998).
   PubMed Web of Science ®Google Scholar
• Ruta DA, Hurst NP, Kind P, Hunter M, Stubbings A. Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br. Rheumatol 37(4), 425–436 (1998).
   Google Scholar
• Geisser ME, Roth RS, Robinson ME. Assessing depression among persons with chronic pain using the Center for Epidemiological Studies - Depression Scale and the Beck Depression Inventory: a comparative analysis. Clin. J. Pain 13(2), 163–170 (1997).
   Google Scholar
• Costigan M, Woolf CJ. Pain: molecular mechanisms. j Painl (3 Suppl. 1), 35–44 (2000).
   Google Scholar
• Hill RG. Peripheral Analgesic Pharmacology - An Update. In: Pain 1999- An updated mview (Max M Ed.), IASP Press, Seattle, USA, 391–395 (1999).
   Google Scholar
• Boucher TJ, Okuse K, Bennett DL, Munson JB, Wood JN, McMahon SB. Potent analgesic effects of GDNF in neuropathic pain states. Science 290(5489), 124–127 (2000).
   PubMed Web of Science ®Google Scholar
• Liu T, van Rooijen N, Tracey DJ. Depletion of macrophages reduces axonal degeneration and hyperalgesia following nerve injury. Pain 86(1-2), 25–32 (2000).
   PubMed Web of Science ®Google Scholar
• Varenna M, Zucchi F, Ghiringhelli D et al. Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double-blind, placebo-controlled study. I Rheumatol 27(6), 1477–1483 (2000).
   Web of Science ®Google Scholar
• Davis KD, Treede RD, Raja SN etal. Topical application of donidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain 47,309–317 (1992).
   Google Scholar
• Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 54(2), 146–165 (1999).
   Google Scholar
• Bennett GJ. Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor. j Pain Symptom Nimage. 19(1 Suppl.), S2-6 (2000).
   Google Scholar
• •Provides a good overview of important mechanisms of neuropathic pain.
   Google Scholar
• Wang YX, Pettus M, Gao D, Phillips C, Scott Bowersox S. Effects of it. administration of ziconotide, a selective neuronal N-type calcium channel blocker, on mechanical allodynia and heat hyperalgesia in a rat model of postoperative pain. Pain 84(2–3), 151–158 (2000).
   Google Scholar
• Wallace MS. Calcium and sodium channel antagonists for the treatment of pain. Clin. J. Pain 16(2 Suppl.), S80-85 (2000).
   Google Scholar
• Khandwala H, Zhang Z, Loomis CW. Inhibition of strychnine-allodynia is mediated by spinal adenosine Al- but not A2-receptors in the rat. Bmin Res 808(1), 106–109 (1998).
   Google Scholar
• Comes JA, Li X, Pan HL, Eisenach JC. Intrathecal adenosine interacts with a spinal noradrenergic system to produce antinociception in nerve-injured rats. Anesthesiology91(4), 1072–1079 (1999).
   PubMed Web of Science ®Google Scholar
• Kesingland AC, Gentry CT, Panesar MS et al. Analgesic profile of the nicotinic acetykholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain. Pain86(1–2), 113–118 (2000).
   Google Scholar
• Meyer MD, Decker MW Rueter LE et al. The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain. Eur Pharmacol 393(1-3), 171–177 (2000).
   PubMed Web of Science ®Google Scholar
• Richardson JD. Cannabinoids modulate pain by multiple mechanisms of action. j Pain 1(1), 2–14 (2000).
   PubMed Web of Science ®Google Scholar
• Richardson JD, Aanonsen L, Hargreaves KM. Antihyperalgesic effects of spinal cannabinoids. Eur. j Pharmacol. (345–2), 145–153 (1998).
   Google Scholar
• Pugh G Jr, Smith PB, Dombrowski DS, Welch SR The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord. J. Pharmacol. Exp. Ther 279(2), 608–616 (1996).
   Google Scholar
• Vane JR, Balchle YS, Botting RM. Cyclooxygenases 1 and 2. Ann. Rev Pharmacol Toxicol 38,97–120 (1998).
   Google Scholar
• •Information contained in this paper provides the reader with information necessary to interpret the clinical importance of the controversies surrounding NSAIDs.
   Google Scholar
• Hawkey C, Kahan A, Steinbruck K et al. Gastrointestinal Tolerability of Meloxicam Compared to Diclofenac in Osteoarthritis Patients. B. j Rheumatol 37,937–945 (1998).
   PubMedGoogle Scholar
• Bombardier C, Lame L, Reicin A et al. Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis. N Engl. Merl 343(21), 1520–1528 (2000).
   Google Scholar
• Silverstein F, Faich G, Goldstein JL et al. Gastrointestinal Toxicity With Celecoxib vs. Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis. The Class Study: A Randomized Controlled Trial. JAIVIA 284(10) 1247–1255 (2000).
   Google Scholar
• Baconja M, Beydoun A, Edwards K et al Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAIVIA 280,1831–1836 (1998).
   PubMed Web of Science ®Google Scholar
• Rowbotham M, Harden N. Stacey B et al Gabapentin for the treatment of post herpetic neuralgia: a randomized controlled trial. JA/V/4. 280,1837–1842 (1998).
   Google Scholar
• Zakrzewska JM, Chaudhry Z and Nurmikko TJ et al. Lamotrigine in refractory trigeminal neuralgia: results from a double-blind placebo-controlled crossover trial. Pain 73(2) 223–230 (1997).
   PubMed Web of Science ®Google Scholar
• Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: a randomized controlled study. Aimology57, 505–509 (2001).
   Google Scholar
• Pappagallo M. Preliminary experience with topiramate in the treatment of chronic pain syndromes. Poster presented at the 17th Annual Meeting, American Pain Society, San Diego, CA, USA (1998).
   Google Scholar
• Tomlinson DR, Malcangio M et al Effects of zonisamide on mechanically induced nociception in rats with streptozotocin-diabetes. Abstract. American Pain Society, Ft. Lauderdale, FL, USA (1999).
   Google Scholar
• Max MB, Lynch SA, Muir J et al. Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl. J. Med. 326,1250–1256 (1992).
   PubMed Web of Science ®Google Scholar
• Enffaard TP, Klitgaard NA, Gram LF, Arendt-Nielson L, Sindrup SH. Specific Effect of Venlafaxine on Single and Repetative Experimental Painful Stimuli in Humans. Gun. Pharmacol. Ther 69(4), 245–251 (2001).
   Google Scholar
• Sumpton JE, Moulin DE. Treatment of Neuropathic Pain with Venlafaxine. Ann. Pharmacother. 35(5), 557–559 (2001).
   PubMed Web of Science ®Google Scholar
• Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 80(3), 533–538 (1999).
   PubMed Web of Science ®Google Scholar
• Devers A, Galer BS. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Gun. Pain 16(3), 205–208 (2000).
   PubMed Web of Science ®Google Scholar
• Robbins WR, Staats PS, Levine J et al. Treatment of intractable pain with topical large doses of capsaicin: Preliminary report. Anesth. Analg. 86,579–583 (1998).
   PubMed Web of Science ®Google Scholar
• Caterina MJ, Schumacher MA, Tominaga M et aL: The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 389,816–824 (1997).
   PubMed Web of Science ®Google Scholar
• Eisenach JC, DuPen S, Dubois M, Miguel R, Allin D. Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group. Pain 61(3), 391–399 (1995).
   Google Scholar
• Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 54(2), 146–165 (1999).
   Google Scholar
• Fromm GH, Aumentado D, Terrence CE A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia. Pain 53(3), 265–271 (1993).
   PubMed Web of Science ®Google Scholar
• Saper JR, Winner PK, Lake AE. An Open- label Dose-titration Study of the Efficacy and Tolerability of Thanidine Hydrochloride Tablets in the Prophylaxis of Chronic Daily Headache. Ikaclache 41(4), 357–368 (2001).
   Google Scholar
• Smith HS, Barton AE. Tizanidine in the Management of Spasticity and Muscoloskeletal Complaints in the Palliative Care Population. Am. j Hosp. Palliat. Care 17(1), 50–58 (2000).
   Google Scholar
• Price DD, Mayer DJ, Mao J, Caruso FS. NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance. j Pain Symptom Manage. 19(1 Suppl.), S7-11 (2000).
   Google Scholar
• Cortet B, Flipo RM, Coquerelle P, Duquesnoy B, Dekambre B. Treatment of severe, recalcitrant reflex sympathetic dystrophy: assessment of efficacy and safety of the second generation bisphosphonate pamidronate. Clin. Rheumatol. 16 (1), 51–56 (1997). D Sommer C, Marziniak M, Myers RR. The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve. Pain 74(1), 83–91 (1998).
   Google Scholar
• Ribeiro RA, Vale ML, Ferreira SH, Cunha FQ. Analgesic effect of thalidomide oninflammatory pain. Eur j Pharmacol 391(1-2), 97–103 (2000).
   PubMed Web of Science ®Google Scholar
• Dellemijn PL, Fields HL. Do benzodiazepines have a role in chronic pain management? Pain 57(2), 137–152 (1994).
   Google Scholar
• Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RII. Amitriptyline butnot lorazepam, relieves postherpetic neuralgia. Aimology38(9), 1427–1432 (1988).
   Google Scholar
• Haythomthwaite JA, Menefee LA, Quatrano- Piacentini AL et al Outcome of chronic opioid therapy for non-cancer pain. j Pain Symptom Manage. 15,185–94 (1998).
   PubMed Web of Science ®Google Scholar
• Gear RVV, Miaskowsld C, Heller PH, Paul SM, Gordon NC, Levine JD. Benzodiazepine mediated antagonism of opioid analgesia. Pain 71(1), 25–29 (1997).
   PubMed Web of Science ®Google Scholar
• Katz N. Neuropathic pain in cancer and AIDS. Gun. j Pain 16(2 Suppl), S41–48 (2000).
   Web of Science ®Google Scholar
• Bennett G, Deer T, Du Pen S, Rauck R, Yaksh T, Hassenbusch SJ. Future directions in the management of pain by intraspinal drug delivery. j Pain Symptom Manage. 20(2), S44–50 (2000).
   Google Scholar
• Patel S, Naeem S, Kesingland A et al The effects of GABA(B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain 90(3), 217–226 (2001).
   PubMed Web of Science ®Google Scholar
• Nishiyama T Gyermek L, Lee C, Kawasaki- Yatsugi S, Yamaguchi T Synergistic analgesic effects of it. midazolam and NMDA or AMPA receptor antagonists in rats. Can. Anaesth. 48(3), 288–294 (2001).
   Google Scholar
• Sawynook J, Reid A. Antinociception by tricyclic antidepressants in the rat formalin test: differential effects on different behabiours following systemic and spinal administration. Pain 93(1), 51–59 (2001).
   PubMed Web of Science ®Google Scholar
• D Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update on effect related to mechanism of drug action. Pain 83,389–400 (1999).
   PubMed Web of Science ®Google Scholar
• VVatson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 50, 1837–1841 (1998).
   PubMed Web of Science ®Google Scholar
• Von Roenn JH, Cleeland CS, Gonin R et al Physician attitudes and practice in cancer pain management. A survey from the Eastern Co-operative Oncology Group. Ann. Intern. Med. 119,121–126 (1993).
   PubMed Web of Science ®Google Scholar
• Benedetti C, Dickerson, ED, Nichols LL. Medical education: A barrier to pain therapy and palliative care. j Pain Symptom Manage. 21(5), 360–362 (2001).
   Google Scholar
• Fundytus ME, Yashpal K, Chabut J et al Knockdown of spinal metabotropic glutamate receptor 1 (mGluR1) alleviates pain and restores opioid efficacy after nerve injury in rats. BE j Pharmacol 132,354–367 (2001).
   PubMed Web of Science ®Google Scholar
• •Research leading to further elucidation of pain mechanisms will lead to the development of unique and effective therapies.
   Google Scholar